Home › Obesity › Florida › Hialeah
Obesity clinical trials in Hialeah, FL
13 studies for Obesity are looking for participants at sites in and around Hialeah (within about 30 miles). Open a study to see who can join and how to contact the study team.
Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
RecruitingPhase 2
- AGA Clinical Trials, Hialeah
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
RecruitingPhase 3
- Miguel Rebollar PA, Hialeah
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
RecruitingPhase 3
- Elite Cardiac Research Center LLC, Hialeah
- Elite Clinical Research, Hialeah
- Panax Clinical Research, Miami Lakes · 4 mi away
- and 2 more
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
RecruitingPhase 2
- Indago Research & Health Center, Inc, Miami Lakes · 4 mi away
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
RecruitingPhase 3
- Elite Cardiac Research Center LLC, Hialeah
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
RecruitingPhase 2
- Indago Research & Health Center, Inc, Miami Lakes · 4 mi away
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
RecruitingPhase 4
- NeoClinical Research, Hialeah
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
RecruitingPhase 3
- Kailera Clinical Site, Miami Lakes · 4 mi away
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
RecruitingPhase 3
- Indago Research and Health Center, Miami Lakes · 4 mi away
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
RecruitingPhase 3
- San Marcus Research Clinic Inc, Miami Lakes · 4 mi away
- Indago Research and Health Center, Miami Lakes · 4 mi away
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
RecruitingPhase 3
- Aga Clinical Trials, Hialeah
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
RecruitingPhase 3
- Inpatient Research Clinic LLC, Miami Lakes · 4 mi away
A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
RecruitingPhase 3
- Angels Clinical Research Institute, Miami Lakes · 4 mi away
About Obesity
Read about the causes of obesity and find out what you can do to decrease your risk of its associated health issues.
More about Obesity on MedlinePlus
Obesity trials in other cities
- Houston, TX44 studies
- Chicago, IL42 studies
- New York City, NY40 studies
- San Antonio, TX39 studies
- Washington, DC33 studies
- Dallas, TX31 studies
- Orlando, FL29 studies
- Boston, MA28 studies
- Miami, FL27 studies
- Las Vegas, NV27 studies
- Atlanta, GA25 studies
- Jacksonville, FL25 studies
Other studies in Hialeah
- Schizophrenia13 studies
- Heart Failure12 studies
- Type 2 Diabetes10 studies
- Overweight10 studies
- Steatotic Liver Disease9 studies
- Atherosclerosis8 studies
- COPD8 studies
- Major Depressive Disorder8 studies
- Cardiovascular Disease6 studies
- Alzheimer's Disease6 studies
- Cancer (all types)6 studies
- Post-COVID Conditions (Long COVID)6 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.